Latest Possis Medical Inc. Stories
Highlights Include Possis Acquisition and Patient Care Innovations WARRENDALE, Pa., March 26 /PRNewswire/ -- MEDRAD, INC.'s revenues grew to over $600 million in 2008, an increase of more than 10 percent over the previous year (excluding the effect of the Possis Medical, Inc. acquisition).
LEVERKUSEN, Germany, and PITTSBURGH, Pennysylvania, March 26 /PRNewswire-FirstCall/ -- Bayer HealthCare affiliate MEDRAD, Inc. announced today that it has successfully completed its tender offer for the outstanding shares of common stock of Possis Medical, Inc. .
Possis Medical, Inc. (NASDAQ:POSS) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its AngioJetÂ® XpeediorÂ® catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins.